278 related articles for article (PubMed ID: 24824313)
1. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
Cao Y; Lindström S; Schumacher F; Stevens VL; Albanes D; Berndt S; Boeing H; Bueno-de-Mesquita HB; Canzian F; Chamosa S; Chanock SJ; Diver WR; Gapstur SM; Gaziano JM; Giovannucci EL; Haiman CA; Henderson B; Johansson M; Le Marchand L; Palli D; Rosner B; Siddiq A; Stampfer M; Stram DO; Tamimi R; Travis RC; Trichopoulos D; Willett WC; Yeager M; Kraft P; Hsing AW; Pollak M; Lin X; Ma J
J Natl Cancer Inst; 2014 Jun; 106(6):dju085. PubMed ID: 24824313
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
3. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
Gu F; Schumacher FR; Canzian F; Allen NE; Albanes D; Berg CD; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Buring JE; Chabbert-Buffet N; Chanock SJ; Clavel-Chapelon F; Dumeaux V; Gaziano JM; Giovannucci EL; Haiman CA; Hankinson SE; Hayes RB; Henderson BE; Hunter DJ; Hoover RN; Johansson M; Key TJ; Khaw KT; Kolonel LN; Lagiou P; Lee IM; LeMarchand L; Lund E; Ma J; Onland-Moret NC; Overvad K; Rodriguez L; Sacerdote C; Sánchez MJ; Stampfer MJ; Stattin P; Stram DO; Thomas G; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Zhang SM; Kaaks R; Riboli E; Ziegler RG; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2877-87. PubMed ID: 20810604
[TBL] [Abstract][Full Text] [Related]
4. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
[TBL] [Abstract][Full Text] [Related]
5. Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer.
Tajtakova M; Pidanicova A; Valansky L; Lachvac L; Nagy V; Sivonova M; Dobrota D; Kliment J; Petrovicova J
Neoplasma; 2010; 57(2):118-22. PubMed ID: 20099974
[TBL] [Abstract][Full Text] [Related]
6. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
[TBL] [Abstract][Full Text] [Related]
7. Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis.
Rainato G; Fabricio AS; Zancan M; Peloso L; Dittadi R; Barichello M; Fandella A; Scattoni V; Gion M
Int J Biol Markers; 2016 Jul; 31(3):e317-23. PubMed ID: 26954072
[TBL] [Abstract][Full Text] [Related]
8. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.
Chen W; Wang S; Tian T; Bai J; Hu Z; Xu Y; Dong J; Chen F; Wang X; Shen H
Eur J Hum Genet; 2009 Dec; 17(12):1668-75. PubMed ID: 19491931
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindström S; Albanes D; Ziegler RG; McCullough ML; Siddiq A; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Crawford ED; Diver WR; Gapstur SM; Giovannucci E; Gu F; Haiman CA; Hayes RB; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Kraft P; Le Marchand L; Overvad K; Polidoro S; Riboli E; Schumacher FR; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Key TJ
Int J Cancer; 2013 Jul; 133(2):495-504. PubMed ID: 23341348
[TBL] [Abstract][Full Text] [Related]
10. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
12. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
[TBL] [Abstract][Full Text] [Related]
13. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.
Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI
Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422
[TBL] [Abstract][Full Text] [Related]
14. Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
Johansson M; McKay JD; Rinaldi S; Wiklund F; Adami HO; Grönberg H; Kaaks R; Stattin P
Prostate; 2009 Sep; 69(12):1281-91. PubMed ID: 19455605
[TBL] [Abstract][Full Text] [Related]
15. Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
Koutros S; Schumacher FR; Hayes RB; Ma J; Huang WY; Albanes D; Canzian F; Chanock SJ; Crawford ED; Diver WR; Feigelson HS; Giovanucci E; Haiman CA; Henderson BE; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Le Marchand L; Riboli E; Siddiq A; Stampfer MJ; Stram DO; Thomas G; Travis RC; Thun MJ; Yeager M; Berndt SI
Cancer Res; 2010 Mar; 70(6):2389-96. PubMed ID: 20197460
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
[TBL] [Abstract][Full Text] [Related]
17. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindstrom S; Schumacher FR; Cox D; Hsing AW; Ma J; Severi G; Albanes D; Virtamo J; Boeing H; Bueno-de-Mesquita HB; Johansson M; Quirós JR; Riboli E; Siddiq A; Tjønneland A; Trichopoulos D; Tumino R; Gaziano JM; Giovannucci E; Hunter DJ; Kraft P; Stampfer MJ; Giles GG; Andriole GL; Berndt SI; Chanock SJ; Hayes RB; Key TJ
Am J Epidemiol; 2012 May; 175(9):926-35. PubMed ID: 22459122
[TBL] [Abstract][Full Text] [Related]
18. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
19. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
Bonilla C; Lewis SJ; Rowlands MA; Gaunt TR; Davey Smith G; Gunnell D; Palmer T; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Grönberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Martin RM; Holly JM
Int J Cancer; 2016 Oct; 139(7):1520-33. PubMed ID: 27225428
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
